Cargando…
PB2286: INFLUENCE OF ANTI-CD20 MONOCLONAL ANTIBODY THERAPY ON THE OUTCOME OF CORONAVIRUS INFECTION COVID-19 IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429197/ http://dx.doi.org/10.1097/01.HS9.0000851972.86710.31 |
| _version_ | 1784779363285204992 |
|---|---|
| author | Zotina, E. Zhelnova, E. Karimova, E. Grishina, E. Paramonova, E. Gagloeva, D. Baryakh, E. Misyurina, E. |
| author_facet | Zotina, E. Zhelnova, E. Karimova, E. Grishina, E. Paramonova, E. Gagloeva, D. Baryakh, E. Misyurina, E. |
| author_sort | Zotina, E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429197 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94291972022-08-31 PB2286: INFLUENCE OF ANTI-CD20 MONOCLONAL ANTIBODY THERAPY ON THE OUTCOME OF CORONAVIRUS INFECTION COVID-19 IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES Zotina, E. Zhelnova, E. Karimova, E. Grishina, E. Paramonova, E. Gagloeva, D. Baryakh, E. Misyurina, E. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429197/ http://dx.doi.org/10.1097/01.HS9.0000851972.86710.31 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Zotina, E. Zhelnova, E. Karimova, E. Grishina, E. Paramonova, E. Gagloeva, D. Baryakh, E. Misyurina, E. PB2286: INFLUENCE OF ANTI-CD20 MONOCLONAL ANTIBODY THERAPY ON THE OUTCOME OF CORONAVIRUS INFECTION COVID-19 IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES |
| title | PB2286: INFLUENCE OF ANTI-CD20 MONOCLONAL ANTIBODY THERAPY ON THE OUTCOME OF CORONAVIRUS INFECTION COVID-19 IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES |
| title_full | PB2286: INFLUENCE OF ANTI-CD20 MONOCLONAL ANTIBODY THERAPY ON THE OUTCOME OF CORONAVIRUS INFECTION COVID-19 IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES |
| title_fullStr | PB2286: INFLUENCE OF ANTI-CD20 MONOCLONAL ANTIBODY THERAPY ON THE OUTCOME OF CORONAVIRUS INFECTION COVID-19 IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES |
| title_full_unstemmed | PB2286: INFLUENCE OF ANTI-CD20 MONOCLONAL ANTIBODY THERAPY ON THE OUTCOME OF CORONAVIRUS INFECTION COVID-19 IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES |
| title_short | PB2286: INFLUENCE OF ANTI-CD20 MONOCLONAL ANTIBODY THERAPY ON THE OUTCOME OF CORONAVIRUS INFECTION COVID-19 IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES |
| title_sort | pb2286: influence of anti-cd20 monoclonal antibody therapy on the outcome of coronavirus infection covid-19 in patients with lymphoproliferative diseases |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429197/ http://dx.doi.org/10.1097/01.HS9.0000851972.86710.31 |
| work_keys_str_mv | AT zotinae pb2286influenceofanticd20monoclonalantibodytherapyontheoutcomeofcoronavirusinfectioncovid19inpatientswithlymphoproliferativediseases AT zhelnovae pb2286influenceofanticd20monoclonalantibodytherapyontheoutcomeofcoronavirusinfectioncovid19inpatientswithlymphoproliferativediseases AT karimovae pb2286influenceofanticd20monoclonalantibodytherapyontheoutcomeofcoronavirusinfectioncovid19inpatientswithlymphoproliferativediseases AT grishinae pb2286influenceofanticd20monoclonalantibodytherapyontheoutcomeofcoronavirusinfectioncovid19inpatientswithlymphoproliferativediseases AT paramonovae pb2286influenceofanticd20monoclonalantibodytherapyontheoutcomeofcoronavirusinfectioncovid19inpatientswithlymphoproliferativediseases AT gagloevad pb2286influenceofanticd20monoclonalantibodytherapyontheoutcomeofcoronavirusinfectioncovid19inpatientswithlymphoproliferativediseases AT baryakhe pb2286influenceofanticd20monoclonalantibodytherapyontheoutcomeofcoronavirusinfectioncovid19inpatientswithlymphoproliferativediseases AT misyurinae pb2286influenceofanticd20monoclonalantibodytherapyontheoutcomeofcoronavirusinfectioncovid19inpatientswithlymphoproliferativediseases |